pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
88
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
Phase 2
← prev
page 2 of 3
next →
131
Pain
89
Neurology
1
KB-801
Neurotrophic Keratitis
$KRYS
Krystal Biotech, Inc.
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
Phase 2
MHB-018A
Graves' Ophthalmopathy
Minghui Pharmaceutical (Shanghai) Co Ltd
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
NexThera Co Ltd
Phase 2
OCU-410
Geographic Atrophy
$OCGN
Ocugen, Inc.
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
Phase 2
OPGx-BEST1
Macular Degeneration
$IRD
Opus Genetics, Inc.
Phase 2
OpRegen
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
Phase 2
Optiquel
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
Phase 2
PER-001
Diabetic Retinopathy
Perfuse Therapeutics Inc
Phase 2
RG-6351
Diabetic Macular Edema
Genentech Inc
Phase 2
RPESCRPE-4W
Dry (Atrophic) Macular Degeneration
Luxa Biotechnology LLC
Phase 2
RY-104
Wet (Neovascular / Exudative) Macular Degeneration
Neuracle Genetics Inc
Phase 2
SAR-402663
Wet (Neovascular / Exudative) Macular Degeneration
$SNY
Sanofi
Phase 2
SAR-446597
Geographic Atrophy
$SNY
Sanofi
Phase 2
SB-007
Juvenile Macular Degeneration (Stargardt Disease)
Splice Bio SL
Phase 2
SHJ-002
Myopia
Sunhawk Vision Biotech Inc
Phase 2
SKG-0106
Wet (Neovascular / Exudative) Macular Degeneration
Skyline Therapeutics (Shanghai) Co Ltd
Phase 2
SPVN-06
Retinitis Pigmentosa (Retinitis)
SparingVision SAS
Phase 2
STMC-103H
Allergies
Siolta Therapeutics Inc
Phase 2
TH-103
Wet (Neovascular / Exudative) Macular Degeneration
$KLRS
Kalaris Therapeutics, Inc.
Phase 2
TTHX-1114
Fuchs Endothelial Corneal Dystrophy (FECD)
Trefoil Therapeutics LLC
Phase 2
Umedaptanib Pegol
Wet (Neovascular / Exudative) Macular Degeneration
Ribomic Inc
Phase 2
VG-801
Unspecified Ophthalmological Disorders
VeonGen Therapeutics GmbH
